2023
DOI: 10.1016/j.heliyon.2023.e21962
|View full text |Cite
|
Sign up to set email alerts
|

Validation of a quantitative liquid chromatography tandem mass spectrometry assay for linezolid in cerebrospinal fluid and its application to patients with HIV-associated TB-meningitis

Marian Mazanhanga,
Anton Joubert,
Sandra Castel
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“…Furthermore, Davis’s study confirmed the safety of linezolid in TBM treatment [ 15 ]. Currently, the Mazanhanga team has developed a method for measuring the concentration of linezolid in cerebrospinal fluid, thus providing a foundation for monitoring the pharmacokinetics of linezolid in the future [ 16 ]. The utilization of linezolid may represent a significant advancement in the management of TBM, potentially playing a crucial role in limiting the transmission of the disease and reducing mortality rates.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, Davis’s study confirmed the safety of linezolid in TBM treatment [ 15 ]. Currently, the Mazanhanga team has developed a method for measuring the concentration of linezolid in cerebrospinal fluid, thus providing a foundation for monitoring the pharmacokinetics of linezolid in the future [ 16 ]. The utilization of linezolid may represent a significant advancement in the management of TBM, potentially playing a crucial role in limiting the transmission of the disease and reducing mortality rates.…”
Section: Discussionmentioning
confidence: 99%